Scarica l'app Stockscreener
6.71
0.07%
0.010
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PRTA Giù?
Forum
Previsione
Prothena Corporation Plc Borsa (PRTA) Ultime notizie
What analysts say about Prothena Corporation plc stockFree AI-Backed Trading Signals - Autocar Professional
What drives Prothena Corporation plc stock priceFree Stock Market Real-Time Monitoring - PrintWeekIndia
Is Prothena Corporation plc a good long term investmentHigh-velocity gains - jammulinksnews.com
Prothena Corporation plc (NASDAQ:PRTA) Receives $31.50 Average Price Target from Analysts - Defense World
Prothena Corporation plc Stock Analysis and ForecastFree Stock Market Forecast Reports - jammulinksnews.com
How to Take Advantage of moves in (PRTA) - news.stocktradersdaily.com
Why Prothena Corporation plc stock attracts strong analyst attentionFree Smart Investment Opportunities - Newser
What makes Prothena Corporation plc stock price move sharplyFree Stock Market Practical Discussion Forums - Newser
How Prothena Corporation plc stock performs during market volatilityFree Capital Allocation Plans - Newser
Cambridge Investment Research Advisors Inc. Acquires Shares of 10,164 Prothena Corporation plc (NASDAQ:PRTA) - Defense World
Piper Sandler Reduces Prothena (PRTA) Price Target to $81 from $110 Following AFFIRM-AL Trial Discontinuation - MSN
PRTA Dives 53.5% YTD: Will the Restructuring Effort Boost Prospects? - sharewise.com
Roche’s Phase 3 Move Boosts Outlook for Prothena Corporation plc (PRTA) - MSN
Prothena to lay off majority of staff; Zealand shares obesity drug data - BioPharma Dive
Peninsula biotech will cut half its workforce, but partner takes Parkinson's drug into late-stage trial - The Business Journals
Prothena announces 63% workforce reduction following birtamimab halt - Investing.com
Prothena (PRTA) Cuts Workforce by 63% to Reduce Costs - GuruFocus
Prothena (PRTA) Shares Rise Following Corporate Restructuring an - GuruFocus
Prothena Announces Major Workforce Reduction to Cut Costs - TipRanks
Prothena (PRTA) Adjusts 2025 Financial Outlook Amid Reorganizati - GuruFocus
Prothena Announces Corporate Restructuring | PRTA Stock News - GuruFocus
Prothena (PRTA) Announces Leadership Changes Amid Workforce Reduction | PRTA Stock News - GuruFocus
Prothena to cut workforce by 63% amid strategic review - Investing.com
Prothena announces corporate restructuring - MarketScreener
Prothena Announces Corporate Restructuring - Business Wire
Chardan Lowers Prothena (PRTA) Price Target Following AFFIRM-AL Trial Failure - MSN
Prothena (NASDAQ:PRTA) Shares Pass Below 200 Day Moving Average – Time to Sell? - Defense World
Roche And Prothena: Why Moving On Makes Sense (OTCMKTS:RHHBY) - Seeking Alpha
(PRTA) Trading Signals - news.stocktradersdaily.com
Financial Analysis: Prothena Corporation plc (PRTA)’s Ratios Unveil Key Insights - DWinneX
Prothena stock rises on Parkinson's trial update (PRTA:NASDAQ) - Seeking Alpha
Prothena’s Prasinezumab Advances to Phase III for Parkinson’s - TipRanks
Prothena partner Roche advances Parkinson’s drug to phase 3 By Investing.com - Investing.com Nigeria
Prothena’s Partner Roche to Advance Prasinezumab into Phase III Development for Early-Stage Parkinson's Disease - BioSpace
Prothena's Partner to Advance Potential Parkinson's Treatment to Phase 3 Development - marketscreener.com
Prothena's Partner Roche to Advance Prasinezumab into Phase III - GuruFocus
1.74%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):